Clinical trial
Efficacy and Safety of Enteric-coated Mycophenolate Sodium in Heart Transplant…
NCT00238446 · Novartis Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00238446 |
|---|---|
| Title | Efficacy and Safety of Enteric-coated Mycophenolate Sodium in Heart Transplant Recipients |
| Official title | A Prospective, Open-label, Multicenter Extension Study on the Efficacy and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in Heart Transplant Recipients |
| Lead sponsor | Novartis Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Patients Successfully Completing the 12-month Treatment Period of the Core Study (de Novo Heart Recipients) Who Were Interested of Being Treated With EC-MPS |
| Intervention type | Drug |
| Interventions | EC-MPS |
| Start date | Apr 1, 2003 |
| Primary completion | Jun 1, 2006 |
| First posted | Oct 13, 2005 |
| Last update posted | Feb 24, 2017 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: